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Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. The
main risk factor for the development of NAFLD is metabolic syndrome. Women are at greatest
risk, typically in their 5th to 6th decade of life. The more aggressive form of NAFLD is
nonalcoholic steatohepatitis (NASH) which is characterized by inflammation associated with
NAFLD. NASH has the greatest tendency to progress into cirrhosis. However, lifestyle
intervention has been shown to effectively treat, and even reverse NAFLD. The purpose of this
quantitative, quasi-experimental study was to lend additional research and demonstrate
improvement in NAFLD through lifestyle intervention with 1) a Mediterranean diet, high in fiber
and low in saturated fat, 2) moderate exercise with walking 90 minutes per week, and 3) social
support group meetings once monthly over a six-month period. Outcomes were measured by 1)
5% total body weight (TBW) loss, 2) improved hepatic steatosis as measured by ultrasound, and
3) improved serum fibrosis staging. There were 20 participants, with a mean age of 53.55 years.
Participants were 85% female, 15% male, 85% Caucasian, 10% African American, and 5%
Hispanic. They received education on a Mediterranean diet, agreed to walk 90 minutes each
week, and attended six support group meetings over a six-month period. At the end of six
months, 90% of participants achieved 5% TBW loss. Diet adherence was shown to be
statistically significant to the prediction of percentage of TBW loss. However, walking and
group meeting attendance were not statistically significant to the prediction of percentage of
TBW loss. With regard to ultrasound outcomes, diet and walking adherence were not found to
be statistically significant; still, diet adherence was noted to make a person 1.75 times more
likely to have a positive ultrasound outcome, with improved fibrosis. Improved postintervention serum fibrosis scores were found to be statistically significant. After careful
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consideration, the greatest limitation of this study was size. This study was too small to
accurately measure the power of all of the independent variables and their impact on NAFLD.
Future studies should include a larger, more diverse population, and be conducted over a longer
period of time. Future studies would also benefit from a multi-disciplinary team approach.
Despite the limitations, the knowledge gained from this research will help shape and advance
current clinical guidelines. Nurse Practitioners (NPs) serve as leaders in lifestyle medicine. NPs
are vital to advancing research and studying the impact lifestyle medicine has on chronic disease,
such as NAFLD.
Keywords: NAFLD, NASH, fibrosis, cirrhosis, exercise, diet, social support in treatment
of chronic disease, weight loss, metabolic syndrome, T2DM, dietary modification,
Mediterranean diet, hyperlipidemia and liver disease, lifestyle modification, lifestyle medicine,
diagnosis, and treatment of NAFLD
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The Impact of Lifestyle Medicine on Nonalcoholic Fatty Liver Disease
CHAPTER 1
Background
Prevalence and Significance of Nonalcoholic Fatty Liver Disease
NAFLD is the most common liver disease worldwide (Bellentani, 2017). It is
characterized by steatosis which is the hepatic accumulation of triglycerides. A major risk factor
for the development of NAFLD is metabolic syndrome which is characterized by diabetes
mellitus type II (T2DM), obesity, and hyperlipidemia. All these disease states endorse the
development of NAFLD through insulin resistance which fosters hepatic accumulation of fatty
acids. NAFLD is regarded as the hepatic component of metabolic syndrome (Andronescu,
Purcarea, & Babes, 2018). It is estimated that 66% of those over the age of 50 with a diagnosis
of diabetes or obesity have NASH with advanced fibrosis (Rinella, 2015).
Women are at greater risk for development of NAFLD, accounting for 65%-83% of
cases, typically peaking in the fifth and sixth decade of life (Andronescu et al., 2018). NAFLD
affects approximately 30% of people in the United States, with another 5% of the population
going on to develop the more aggressive form of NAFLD, NASH. Additionally, half of all
deaths in those with NASH are secondary to cardiovascular disease and malignancy (Rinella,
2015). NASH has the propensity to progress into cirrhosis, being the 11th leading cause of death
in the United States in 2017 (Kochanek et al., 2019). NASH cirrhosis is predicted to be the
leading indication for liver transplantation in the United States by the year 2020 (Corey &
Chalasani, 2014).
Other risk factors for the development of NAFLD and fatty liver disease are alcohol
dependence, viral hepatitis, rapid weight loss resulting from gastric bypass surgery, certain
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medications, and long-term total parenteral nutrition infusion. The most common medications
associated with NAFLD are amiodarone, glucocorticosteroids, tetracyclines, zidovudine, and
tamoxifen (Andronescu et al., 2018).
As the occurrence of obesity and T2DM has continued to grow, so too has NAFLD (Ma
et al., 2018). Globalization of a Western diet, improved access to food, and sedentary lifestyles
are believed to be responsible for the upward trend in the global prevalence of NAFLD.
Lifestyle modification that promotes weight loss through improved dietary habits and exercise
has been recommended for treatment of NAFLD. Studies showing improved eating habits and
dietary counseling throughout one year with a weight loss of 7% or more may improve the
histopathologic features of NASH (Ahmed, Wong, & Harrison, 2015). Ahmed et al. (2015) go
on to assert that patients who also incorporated exercise during this one-year period
demonstrated more long-term weight loss.
The Impact of Lifestyle Medicine on NAFLD
Lifestyle intervention is the foundation of treatment for NAFLD. Pharmacologic
therapies are limited and have failed to provide long-term improvement (Worcester, 2014).
However, diet, exercise, and social support leading to weight loss have proven very effective in
the treatment of NAFLD.
The Mediterranean diet has been associated with weight loss, improved cardiovascular
health, and reduced hepatic fat accumulation (Ma et al., 2018). The Mediterranean diet is
primarily plant-based. It is made up of fruits, vegetables, nuts, legumes, whole grains, and fish,
with moderate consumption of poultry, eggs, cheese, and yogurt. Red meat is avoided and
saturated fats and butter are replaced with extra virgin olive oil and canola oil. In addition to the
dietary guidelines outlined in the Mediterranean diet, the recommended caloric intake for weight

SCHOLARLY PROJECT

9

loss in women is 1000-1200 calories per day and 1200-1600 calories per day for men (Ahmed et
al., 2015).
Complications arising from metabolic syndrome, T2DM, and obesity in patients with
NAFLD are further exaggerated by a sedentary lifestyle and lack of aerobic exercise. Regular
exercise promotes protein synthesis and expands muscle mass, while a sedentary lifestyle results
in muscle breakdown (Ahmed et al., 2015). Aerobic activity, such as swimming or running, for
120 minutes each week promotes insulin sensitivity through building lean muscle mass, which
promotes more efficient glucose uptake. This leads to reduction in accumulation of hepatic fat,
offering protection against NAFLD (Keating, Hackett, George, & Johnson, 2012).
Lifestyle change and behavioral modification are difficult for most individuals.
Middleton, Anton, and Perri (2013) found that people who participated in social support
provided in a group setting had an increased perceived ability to adhere to lifestyle modifications
and were better equipped to manage barriers to long-term change. Middleton et al. (2013) note
that when providers are conducting group-based interventions, it is important to allow group
members to share health knowledge when appropriate and help guide self-discovery to potential
solutions during problem solving. This promotes self-efficacy among group members.
Purpose of Research
Lifestyle modification is the foundation for treating NAFLD. Unfortunately, research is
limited on this topic. The purpose of this study was to demonstrate improvement in NAFLD
through lifestyle intervention with 1) a Mediterranean diet, high in fiber and low in saturated fat,
2) moderate exercise by walking 90 minutes per week, and 3) social support group meetings
once monthly over a six-month period. It is hoped that this study will also lead to improved
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long-term health outcomes in patients with NAFLD, as well as augmenting additional research in
the treatment of NAFLD.
Clinical Question
In patients with NAFLD, does 1) a Mediterranean diet, high in fiber and low in saturated
fat, 2) moderate exercise with walking 90 minutes per week, and 3) social support group
meetings once monthly over a six-month period show disease improvement? Outcomes were
measured by 1) 5% TBW loss, 2) improved hepatic steatosis as measured by ultrasound
(obtained at baseline and repeated at six months), and 3) improved fibrosis staging through
measurement of Echosens FibroMeter (obtained at baseline and repeated at six months).
Concepts and Definition of Terms
The following provides an explanation of related definitions with regard to this study.
Nonalcoholic Fatty Liver Disease (NAFLD). Encompasses the entire spectrum of fatty
liver disease in individuals without significant alcohol consumption, ranging from fatty liver to
steatohepatitis and cirrhosis.
Nonalcoholic Fatty Liver (NAFL). Presence of hepatic steatosis with no evidence of
hepatocellular injury in the form of ballooning of the hepatocytes or no evidence of fibrosis. The
risk of progression to cirrhosis and liver failure is minimal.
NAFLD Activity Score (NAS). Represents the sum of scores for steatosis, lobular
inflammation, and ballooning, ranging from 0-8.
Nonalcoholic Steatohepatitis (NASH). Presence of hepatic steatosis and inflammation
with hepatocyte injury (ballooning) with or without fibrosis. This can progress to cirrhosis, liver
failure, and rarely liver cancer.
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NASH Cirrhosis. Presence of cirrhosis with current or previous histological evidence of
steatosis or steatohepatitis.
Fibrosis. Formation of abnormally large amount of scar tissue in the liver in an attempt
to repair or replace damaged cells. Severe scarring from fibrosis can progress to cirrhosis.
Stages of fibrosis: F0 (without fibrosis), F1 (portal fibrosis without septa), F2 (portal fibrosis
with rare septa), F3 (bridging septa between the central veins and the portal veins), and F4
(cirrhosis).
Lifestyle Medicine. One aspect of medicine centered on research, prevention, and
treatment of disorders resulting from lifestyle factors. It focuses on the predominate use of a
whole food, plant-based diet, regular physical activity, sleep, stress management, and positive
social networks to treat, reverse, and prevent chronic disease.
Theoretical Framework
The clinical use of nursing models and theories help facilitate expansion of nursing
knowledge. It is an essential phase for achieving the goals that influence the practical
application of clinical and educational research. For the purposes of this study, the Neuman
Systems Model and CREATION Health Model was utilized.
The Neuman Systems Model was created in the 1970s by nursing theorist Betty Neuman.
It is a broad system, wholistic theory that suggests the nature of living organisms are open
systems that interact with each other and their environment. Neuman (1996) wrote that patients
are not defined by their illness or injury; rather, we need to view them as an entire person. The
Neuman Systems Model is constructed around the relationship and reaction a patient has with
stress, and the dynamic nature of reconstitution factors that help the individual fight against and
recover from stress. There are three lines of defense central to Neuman’s theory: 1) lines of
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resistance that represent internal factors that allow the patient to fight against stress; 2) the
normal line of defense, which represents a patient’s equilibrium; and 3) the flexible line of
defense, which represents dynamic factors that can quickly change in a short amount of time.
The nurse endorses stability through utilization of three levels of prevention: 1) primary
prevention, which defends the normal line of defense and strengthens the flexible line of defense;
2) secondary prevention, which is used to strengthen the internal lines of resistance, thereby
reducing the reaction and increasing resistance factors; and 3) tertiary prevention, which
stabilizes, and guards the patient’s return to wellness following treatment. Within the Neuman
Systems Model the client may be an individual, family, group, community, or social entity
(Neuman, 1996).
The CREATION Health model uses Biblical principles supported by evidenced-based
science for wholistic living, focusing on mind, body, and spirit. Each letter in CREATION
represents a different component for good health: Choice, Rest, Environment, Activity, Trust,
Interpersonal Relationships, Outlook, and Nutrition (Hickey, 2014).
When applying Neuman’s theory to this study, the person with NAFLD was at the center
with the emphasis placed on their liver. The normal line of defense was represented by the
caring, connecting, empowering received from family, peers, and the nurse practitioner (NP).
Diet, exercise, and weight loss served as the flexible line of defense against liver disease.
This study was further supported by the CREATION health model with four obvious
aspects: 1) Choice, because patients chose to participate in this study and to implement lifestyle
change; 2) Activity, through walking to help improve NAFLD; 3) Interpersonal relationships,
through participation in monthly support group meetings; and 4) Nutrition, demonstrated by
following a low-fat, high-fiber diet. The less obvious principles included Rest, Environment,
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Trust in God, and Outlook. Rest, because it is essential to good health through lowering blood
pressure, relaxation, and stress reduction. Environment, both external and internal
environmental influences impact overall health and well-being. Trust in God and recognizing
the link between spirituality and healing endorses our physical and spiritual health. Finally, our
outlook toward life and how we view circumstances creates our reality. Our mind influences our
physical body and attitude toward health. All of these components together are essential in the
prevention, treatment, and reversal of disease in patients with NAFLD.
Conceptual Model
Figure 1
Conceptual Model

This conceptual model integrates components of the Neuman Systems Model and the CREATION Health Model.

As depicted in Figure 1, at the center of this conceptual model is the person with
NAFLD, with emphasis being placed on healthy liver function and disease reversal. The normal
lines of defense are represented through caring, connecting, and empowering, received from
family, peers, and the NP. This line of defense provides balance to competing stressors that
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impede successful management and reversal of liver disease. The flexible lines of defense, being
the most dynamic because of how quickly they can change, are represented through weight loss,
exercise, and nutrition. These lifestyle modifications require Choice as a first step, because
before an individual can achieve nutrition, exercise, and weight loss, they must first choose to
make changes in these areas.
As the role of the NP continues to grow and evolve, so too will the impact NPs have on
the face of health care in the United States and globally. Considering that most of the chronic
disease NPs treat today is a result of poor lifestyle choices, there is a responsibility to include
lifestyle modification as a way to prevent and treat chronic disease, such as NAFLD. Diet and
physical activity ought to be regarded as medicine, and equally important to patient outcomes.
NPs are going to have to become adept at applying the principles of lifestyle medicine and
become leaders in their community, promoting good health, and advocating for those in
underserved communities. They also need to actively participate in research that will further
expand their role as health care leaders, particularly in lifestyle medicine.
NAFLD is the most common liver disease globally and is regarded as the hepatic
component of metabolic syndrome (Andronescu et al., 2018). Attributing factors include
sedentary lifestyles, globalization of a Western diet, and improved access to food (Ahmed et al.,
2015). Patients with NAFLD that go on to develop NASH are at the greatest risk, given NASH
has the propensity to progress into cirrhosis. If nothing is done to intervene in the state of our
health care, NASH cirrhosis is predicted to be the leading indication for liver transplantation in
the United States (Corey & Chalasani, 2014). This study demonstrates and replicates findings
from previous studies that show lifestyle modification can result in disease regression and
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CHAPTER 2
LITERATURE REVIEW

NAFLD accounts for the majority of chronic liver disease in the U. S. and has the
propensity to progress into cirrhosis (Singh et al., 2015). Lifestyle modification is the only longterm treatment for management of this disease. Weight loss, improved diet, and exercise can
reduce aminotransferases and improve hepatic steatosis, as demonstrated by ultrasound and
magnetic resonance imaging (Chalasani et al., 2018). Patients who are overweight are much
more likely to have increased insulin resistance, diabetes, and hypertriglyceridemia, placing them
at greater risk for the development of NAFLD. While lifestyle modification with diet and
exercise have been recognized as effective therapeutic strategies for diabetes and cardiovascular
disease, research is limited providing similar recommendations for NAFLD. Current clinical
guidelines recommend weight loss of at least 3% - 5% of total body weight (TBW) to improve
steatosis, however greater weight loss of 10% TBW may be needed to improve
necroinflammation. It is recommended this weight loss should be achieved through a
hypocaloric diet alone or concurrently with exercise. Regular exercise is also recommended in
adults with NAFLD, as exercise independent of dietary modification may reduce hepatic
steatosis. However, its ability to improve other features of liver histology remain undetermined
(Chalasani et al., 2018).
An extensive literature review was conducted using the Cumulative Index to Nursing and
Allied Health Literature (CINAHL) and the American Gastroenterological Association (AGA).
Keywords used included: NAFLD, NASH, fibrosis, cirrhosis, exercise, diet, social support in
treatment of chronic disease, weight loss, metabolic syndrome, T2DM, dietary modification,
Mediterranean diet, hyperlipidemia and liver disease, lifestyle modification, lifestyle medicine,
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diagnosis, and treatment of NAFLD. Studies were excluded based on a diagnosis of cirrhosis,
alcohol and/or drug induced etiology, viral hepatitis, and human immunodeficiency virus.
Fourteen studies were chosen for this review, published between 2004-2018. Following
summary of the literature findings, organized by three identified themes: 1) progression of
fibrosis; 2) lifestyle modification (diet, exercise, social support) for the treatment of fibrosis and
NAFLD.
Progression of Fibrosis
Fibrosis can progress into cirrhosis. However, little is known about the difference in
fibrosis progression rates between NAFLD and NASH. Singh et al. (2015) conducted a
systematic review and meta-analysis of all available research that assessed paired liver biopsies
in patients with NAFLD and NASH to estimate the rate of fibrosis progression. A total of 11
cohort studies were used for analysis. The researchers identified 411 patients with biopsies
confirming NAFLD, 150 patients with NAFLD and 261 with NASH. Of the 11 studies included
in this meta-analysis, eight were obtained from Western populations and three from Asian
populations. The average age of participants ranged from 44 to 55 years with 53% being men.
The mean BMI ranged from 27.4 to 37.7 kg/m², and 49.9% of participants were diabetic. The
distribution of fibrosis at baseline was stage 0 (35.8%), stage 1 (32.5%), stage 2 (16.7%), stage 3
(9.3%), and stage 4 (5.7%). Follow-up evaluation was over 2145.5 person-years. During this
time, 33.6% (n = 138) had progression by one fibrosis stage when compared to baseline, 43.1%
(n = 177) remained stable, and 22.3% (n = 96) had improvement with a decrease by at least one
fibrosis stage when compared to baseline. The annual fibrosis progression rate for the NAFLD
patients who had fibrosis stage 0 at baseline was 0.07 stages (95% CI, 0.02-0.11 stages) and
patients with NASH progressed 0.14 stages (95% CI, 0.07-0.21 stages). These findings showed
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that NAFLD had a fibrosis progression rate of one fibrosis stage over 14.3 years (95% CI, 9.150.0 y), compared to NASH that progressed one fibrosis stage over 7.1 years (95% CI, 4.8-14.3
y) (Singh et al., 2015).
This meta-analysis demonstrated that fibrosis can progress in patients with NAFLD and
NASH. The progression rate of one fibrosis stage for NASH was twice as rapid as noted in
NAFLD. Singh et al. (2015) suggested that NAFLD embodies a complex relationship between
genetic, environmental, and intrinsic factors; therefore, the natural progression of NAFLD is
likely modifiable through lifestyle modification and is not a universally progressive condition.
Lifestyle Modification
Vilar-Gomez et al. (2015) conducted one of the first large prospective studies exploring
the impact of lifestyle modification on the histologic features of NASH. They followed 293
clinic patients in Havana, Cuba with histologically proven NASH. Mean age of participants was
48.5 years, 59% were women, and average BMI was 31.3. Approximately one-third of
participants had T2DM and more than half had hypertension. Of the participants with metabolic
syndrome, 63% had at least three components of the syndrome. Patients were encouraged to
reduce their weight and placed on a low-fat hypocaloric diet that was 750 kcal/d less than their
daily energy requirement. Dietary guidelines were proportionally distributed: carbohydrates
64%, fat 22% with < 10% of saturated fatty acids as part of their total daily caloric intake, and
protein 14%. Patients were also encouraged to walk 200 minutes each week. Additionally, all
participants received individual counseling sessions every eight weeks to promote compliance.
Medications with potential benefit for NASH, such as glitazones and vitamin E, were prohibited
during this study. Patients with hyperlipidemia who had not been on previous treatment, whose
lipid profiles did not improve after three months of lifestyle intervention, were started on lipid-
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lowering agents per guidelines. Baseline and follow-up measurements included age, sex, weight,
BMI, waist circumference, laboratory tests (alanine aminotransferase, asparartate
aminotransferase, uric acid, cholesterol, triglycerides, fasting glucose, and the Homeostatic
Model Assessment of Insulin Resistance Index), and liver biopsies at initiation and at conclusion
of study.
After 52 weeks of lifestyle change, paired liver biopsies were available from 261 out of
293 participants. Results showed 72 (25%) attained resolution of steatohepatitis, 138 (47%) had
reductions in NAFLD activity scores (NAS), and 56 (19%) demonstrated improvement of
fibrosis. By the end of the study, 88 (30%) participants lost ≥ 5% TBW. Vilar-Gomez et al.
(2015) demonstrated improvement in all NASH-related histological parameters independent of
the amount of weight loss (odds ratios = 1.1 - 2.0; p < .01). However, they did note those with ≥
5% loss in TBW were more likely to achieve NASH resolution (51 of 88 [58%]) and a two-point
reduction in NAS (72 of 88 [82%]), when compared to those with < 5% loss of TBW (p < .001).
All those with ≥ 10% loss of TBW had reductions in NAS, 90% achieved resolution of NASH,
and 45% demonstrated improved fibrosis. Additionally, participants with risk factors who lost
7% - 10% in TBW also demonstrated reduced NAS. This study also noted a significant
reduction in NAS in female participants who lost > 10% TBW who had a baseline BMI ≥ 35,
fasting glucose > 5.5 mmol/L, and many ballooned cells noted with liver biopsy (Vilar-Gomez et
al., 2015).
To date, this is one of the largest prospective studies showing empirical evidence
supporting weight loss for treatment of NAFLD. Vilar-Gomez et al. (2015) concluded that
modest TBW loss of 7% - 10% significantly improved NAFLD activity score. Those with more
significant weight loss ≥ 10% TBW accomplished the highest rates of NASH resolution.
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Therefore, in patients with NAFLD who are overweight or obese, lifestyle modification that
promotes weight loss is essential to ensuring best clinical outcomes.
Promrat et al. (2010) conducted a randomized control trial (RCT) studying 31 obese
patients with NASH. Half were randomly assigned to an intensive lifestyle intervention group
and the other half were placed in the control group, receiving basic structured dietary education
alone. The intensive lifestyle group had to participate in a hypocaloric diet, behavior
modification, and 200 minutes a week of moderate physical activity for 48 weeks. The
intervention group had 9.3% weight loss versus 0.2% in the control group. Participants with ≥
7% TBW showed greatest improvement in steatosis, lobular inflammation, ballooning, and NAS.
Promrat et al. (2010) concluded that lifestyle intervention with diet, behavior modification, and
exercise leads to improvement in the histologic features of NASH.
Many studies have recommended dietary modification for treatment of NAFLD, but
research is limited in determining if improving diet quality can prevent the development of
NAFLD. Ma et al. (2018) conducted a prospective study examining the association between
change in diet quality and change in liver fat accumulation and to explore if diet quality modifies
genetic risk for NAFLD. This study looked at 1521 participants gathered from the second and
third-generation cohorts from the Framingham Heart study. Two diet scores, Mediterraneanstyle diet score (MDS) and Alternative Healthy Eating Index (AHEI) score, were evaluated to
assess for changes in liver fat and new-onset of fatty liver. The Harvard food frequency
questionnaire was used to calculate MDS and AHEI scores at both baseline and follow-up.
Levels of liver fat were assessed using CT imaging from baseline and at follow-up to calculate
liver phantom ratio (LPR). LPR values are inversely related to liver fat. Genetic risk score
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(GRS) was calculated by adding together the number of NAFLD-associate risk alleles and the
corresponding regression coefficient.
Ma et al. (2018) observed that each standard deviation (SD) serial increase in MDS score
from baseline to follow-up showed significant reduction in liver fat accumulation as measured by
LPR with a decrease by 0.57 (95% CI 0.27-0.86; p < .001). Likewise, for each SD increase in
AHEI score the corresponding decline in LPR was 0.56 (95% CI 0.29-0.84; p < .001). Both
increased MDS and AHEI scores showed a reduction in the development of incidental fatty liver.
There was a 26% decline with one SD increase in MDS (95% CI10% - 39%; p = .002) and a
21% decline with one SD increase in AHEI (95% CI 5% - 35%; p = .02). Also noted was a
significant interaction between GRS and MDS. Among those patients with declining MDS
scores from baseline to follow-up, there was a significant association between NAFLDassociated GRS and increased liver fat accumulation (p < .001). Likewise, similar results were
noted to be significant between GRS and declining MDS (p < .001) and AHEI scores (p < .001),
but not in those participants whose diet improved or remained stable (p for gene-diet interaction
< .001).
Ma et al. (2018) concluded that improved eating habits were associated with reduced risk
for developing NAFLD. Additionally, it was thought that adopting a healthier diet may abate an
individual’s genetic predisposition to NAFLD. These associations were largely driven by
increased consumption of fruits, vegetables, nuts, legumes, whole grains, EPA and DHA omega3 fatty acids, and decreased consumption of red meat and trans-fat.
Exercise is known to promote weight loss and has been theorized to improve features of
NASH. Houghton et al. (2017) conducted a randomized controlled trial to evaluate the effect of
exercise on NASH, independent of dietary change. Twenty-four patients with NASH, as
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diagnosed with liver biopsy, who reported a sedentary lifestyle with less than 60 minutes of
vigorous activity weekly, were studied to evaluate the benefits of exercise on NASH, irrespective
of dietary intervention. Subjects were randomly assigned to the group that exercised (n = 12)
and the group that continued standard treatment (n = 12). The exercise group participated in
cycling and strength training supervised by an exercise physiologist for three nonconsecutive
days each week for a 12-week period, while maintaining their current weight. Baseline
measurements and at 12 weeks included hepatic triglyceride content (HTGC), body mass index,
serum inflammatory markers, hepatic fibrosis, and glucose tolerance. The goal of this study was
to measure only the effect of exercise on NASH if no dietary changes were made through
measurement of HTGC and biomarkers of fibrosis. Measurements obtained at the end of 12
weeks, when compared to baseline measurements, showed significant improvement of HTGC
(reduction of 16% ± 24% vs. an increase of 9% ± 15% for controls; p < .05), visceral fat
(reduction of 22 ± 33 cm² vs. an increase of 14 ± 48 cm² for controls; p < .05), serum
triglycerides (reduction of 0.5 ± 1.0 mmol/L vs. an increase of 0.3 ± 0.4 mmol/L for controls; p <
.05), and y-glutamyltransferase (reduction of 10 ± 28 U/L-¹ vs. a reduction of 17 ± 38 U/L-¹ for
controls; p < .05).
Houghton et al. (2017) observed that after 12 weeks of vigorous exercise three days each
week, there was a 16% reduction in liver fat, a 12% reduction in visceral fat, a 23% reduction in
circulating triglyceride levels, and a 4% increase in lean body mass. Conversely, 12 weeks postintervention showed no significant effect on glucose control, inflammatory markers, liver
enzyme levels, or NAS. This study shows the clinical value of exercise as part of the treatment
for NASH, as evidenced with improvement in HTGC and visceral fat. However, exercise
without weight loss affects some, but not all, factors with NASH. Therefore, treatment of

SCHOLARLY PROJECT

23

NAFLD and NASH needs to include exercise with weight management strategies to optimize
long-term health outcomes.
Lifestyle change can be difficult for some to achieve and maintain. Social support has
been shown to significantly improve adherence to lifestyle change, while the absence of social
support has been associated with less favorable outcomes (Middleton et al., 2013). Research has
also suggested that patients who did not have practical social support were twice as likely to fail
to maintain lifestyle change, compared to those who did (DiMatteo, 2004). Additionally,
patients who were recruited along with family and friends for weight management regained 0.1
kg at their six-month follow up, while patients recruited alone regained 1.6 kg (Middleton et al.,
2013). Group support has also shown improved outcomes when compared to individual
treatment. Group cohesion augments the effectiveness of treatment and promotes compliance
with diet and physical activity through enhancing participants’ perceived ability to comply with
behavior change and navigate barriers to long-term change (Middleton et al., 2013).
Summary
NAFLD, the hepatic expression of metabolic syndrome, has risen to be the leading cause
of liver disease worldwide and is associated with increased risk for diabetes and heart disease
(Vilar-Gomez, 2015). Several studies have evaluated the impact of diet on NAFLD, and a fair
amount of these incorporate exercise and weight loss for treatment and disease reversal.
However, few assess or even address the impact of social connection and support, failing to
recognize the importance of connecting mind, body, and spirit in order to optimize long-term
clinical outcomes. As research has demonstrated, treatment for NAFLD requires lifestyle
modification that incorporates weight loss with improved diet quality, exercise, and social
support to ensure best patient outcomes. The purpose of this project was to demonstrate
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improvement in NAFLD utilizing lifestyle intervention that incorporates a holistic approach,
through improved dietary habits, regular exercise, and social support amongst peers.
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Chapter 3
Methodology

As stated previously, new approaches in lifestyle modification are needed to improve
outcomes in patients with NAFLD. The purpose of this study was to demonstrate improvement
in NAFLD through lifestyle intervention with 1) a Mediterranean diet, high in fiber and low in
saturated fat, 2) moderate exercise by walking 90 minutes per week, and 3) social support group
meetings once monthly over a six-month period. It is hoped that this study will also lead to
improved long-term health outcomes in patients with NAFLD, as well as augmenting additional
research in the treatment of NAFLD.
Design
This quantitative study utilized a quasi-experimental research design to establish a causeeffect relationship between lifestyle modification, as demonstrated through improved diet,
regular exercise, and social support, and how those variables impact NAFLD. Control groups
and randomization were not utilized for this study.
Study Participants
Twenty study participants were recruited from a gastroenterology practice in Southeast
Tennessee. Inclusion criteria was a diagnosis of NAFLD/NASH with fibrosis ranging from stage
F0 to F3 as determined from hepatic ultrasound and Echosens FibroMeter. This study did not
discriminate based on age, sex, or ethnicity. Participant exclusions included those with cirrhosis,
prior history of alcohol/drug dependence, refusal to abstain from alcohol consumption
throughout the course of this study, viral hepatitis, pre-existing medical conditions preventing
participation in walking, and autoimmune liver disease.
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Ethical Considerations
Institutional review board (IRB) approval was obtained prior to implementation. Risk to
human subjects was limited based on the Six Aims for Healthcare Improvement (IOM, 2001),
which states that research and healthcare improvement should be safe, effective, patientcentered, timely, efficient, and equitable.
Safety for participants was demonstrated by avoiding injuries from care intended to help.
There were no invasive procedures associated with this study, other than venipuncture for
monitoring serological response to interventions. Services provided over the course of this study
were based on scientific knowledge and current clinical guidelines, as outlined throughout this
paper. Participants were determined based on a diagnosis of NAFLD and participation was only
offered to those who would benefit from participating in this study. Care was patient-centered,
respectful, and responsive to individual preferences and needs. Participant values guided all
clinical decisions, and services provided were timely. There were no interventions that could
result in harm related to delays in care. Care was efficient, avoiding waste of equipment,
supplies, and energy. All health outcomes were evaluated based on current American
Association for the Study of Liver Diseases (AASLD) clinical guidelines. Finally, care was
equitable to all participants and did not vary in quality because of personal characteristics such as
gender, ethnicity, geographic location, or socioeconomic status.
Intervention
Participants were provided with recommendations for lifestyle modification and followed
for six months. The dietary interventions consisted of a Mediterranean diet which was primarily
a plant-based diet including vegetables, fruits, nuts, legumes, whole grains, and nuts. Butter and
animal fat were replaced with healthier fats, such as olive oil and canola oil. Participants were
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encouraged to limit sodium and use more herbs and spices to flavor their food. Red meat was
replaced with fish and poultry and limited to twice a week. Participants were also asked to drink
a minimum of 64 ounces of water each day. Additionally, participants agreed to walk a
minimum of 90 minutes a week and attend a total of six support group meetings.
Description of Measures
A multiple linear regression model was utilized to predict percent of TBW loss based on
three independent variables: adherence to a Mediterranean diet, walking 90 minutes each week,
and participating in six social support group meetings over a six-month period. Multiple linear
regression predicts a continuous dependent variable based on multiple independent variables. It
also allows for determination of the overall fit, explaining variance of the model and the relative
contribution of each of the predictors to the total variance explained (Laerd Statistics, 2019).
A logistic regression model was used to predict improved ultrasound outcome based on
two independent variables, adherence to following a Mediterranean diet and adherence to
walking, over a six-month period of time. Logistic regression predicts the probability that a
dichotomous dependent variable can be explained by one or more independent variables that are
either continuous or categorical (Laerd Statistics, 2019).
Initial measurements included height, weight, BMI, blood pressure, liver function tests,
fasting lipid panel, hepatic ultrasound, and Echosens FibroMeter. These same measurements
were repeated at the conclusion of this study and a Wilcoxon signed-rank test was utilized to
ascertain if there was a median difference between paired, pre-intervention and post-intervention
observations. Outcomes were measured by five percent TBW loss, improved hepatic steatosis as
measured by hepatic ultrasound (obtained at baseline and repeated at six months), and improved
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fibrosis staging through measurement of Echosens FibroMeter (obtained at baseline and repeated
at six months). The findings were considered statistically significant if p < .05.
Data Analysis Procedures
Utilizing IBM SPSS ® 26 software, the data collected in this quasi-experimental
quantitative study was evaluated using multiple linear regression to predict the percent in TBW
loss and for patients with NAFLD based on three independent variables; adherence to a
Mediterranean diet, walking 90 minutes each week, and participating in six social support group
meetings over a six-month period. Participant compliance for adherence to diet, exercise, and
group meetings was measured using a Likert scale (0 = never, 1 = less than half of the time, 2 =
at least half of the time, and 3 = always). Outcomes were measured using nominal variables, 1)
5% TBW loss (0 = no, 1 = yes), 2) improved hepatic steatosis as measured by ultrasound (0 = no,
1 = yes), 3) improved fibrosis staging through measurement of Echosens FibroMeter (0 = no, 1 =
yes).
This study met the eight assumptions required for multiple linear regression. These
assumptions must be met in order to determine accuracy of predictions, which tests how well the
regression model fits the data, thereby determining the variation in the dependent variable
explained by the independent variables, and testing the hypotheses on the regression equation
(Laerd Statistics, 2019).
Assumption one, there was a continuous dependent variable, NAFLD. Assumption two,
there were three independent variables: Mediterranean diet, walking 90 minutes each week, and
participating in six social support group meetings. Assumption three, independence of
observations, was checked using the Durbin-Watson statistic. Assumption four, a scatterplot of
the standardized residuals against the unstandardized predicted values, demonstrated a linear
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relationship between the dependent variable and each of the three independent variables.
Additionally, a partial regression plot shows that a linear relationship existed between NAFLD
and each of the independent variables. Assumption five, homoscedasticity of residuals and equal
error variances, was checked by plotting the studentized residuals against the unstandardized
predicted values. Assumption six, was met because the data did not show multicollinearity
through inspection of correlation coefficients and Tolerance/VIF values. Assumption seven, no
significant outliers with high leverage or influential points, was determined utilizing Cook’s
Distance. Lastly, assumption eight, normal distribution, was checked using a histogram with
superimposed normal curve and a P-P Plot.
A logistic regression model was used to predict improved ultrasound outcome based on
two independent variables, adherence to following a Mediterranean diet and adherence to
walking, over a six-month period of time. Additionally, a Wilcoxon signed-rank test was
utilized to ascertain if there was a median difference between paired, pre-intervention, and postintervention observations of weight, BMI, blood pressure, fasting lipid panel, hepatic ultrasound,
and fibrosis score.
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Chapter 4
Analysis of Results

This study used multiple linear regression to predict the percent in TBW loss for patients
with NAFLD based on three independent variables: adherence to a Mediterranean diet, walking
90 minutes each week, and participating in six social support group meetings over a six-month
period. A logistic regression model was used to predict improved ultrasound outcome based on
two independent variables, adherence to following a Mediterranean diet and adherence to
walking. Additionally, measurements for weight, blood pressure, fasting lipid panel, hepatic
ultrasound, and fibrosis score were measured pre- and post-intervention, and a Wilcoxon signedrank test was utilized to ascertain if there was a median difference between paired observations.
Outcomes were measured by 5% TBW loss, improved hepatic steatosis as measured by hepatic
ultrasound, and improved fibrosis staging, as measured by Echosens FibroMeter.
Participation and Demographic Characteristics
Participants were recruited from a gastroenterology practice in Southeast Tennessee, with
a diagnosis of NAFLD/NASH, fibrosis ranging from stage F0 to F3. They were followed for six
months and asked to adhere to a Mediterranean diet, walk a minimum of 90 minutes a week, and
attend a total of six support group meetings.
Ages of participants ranged from 18 to 78 with a mean of 53.55 years. Gender was
comprised of 85% female (n = 17) and 15% male (n = 3). Eighty-five percent of participants
were Caucasian (n = 17), 10% African American (n = 2), and 5% Hispanic (n = 1). Ninety
percent (n = 18) achieved 5% TBW loss and 10 % (n = 2) did not. The demographics and
contributing variables of group participants have been depicted in Appendix A.
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Compliance with diet, walking, and group meeting attendance was measured using a
Likert scale questionnaire, depicted in Appendix D. Fifty-five percent (n = 11) reported always
following the diet, 40% (n = 8) at least half of the time, and 5% (n = 1) less than half the time.
Sixty percent (n = 12) reported walking 90 minutes each week, 35% (n = 7) walked at least 45
minutes each week, and 5% (n = 1) reported not walking. Eighty percent (n = 16) of participants
attended all six group meetings, 15% (n = 3) attended at least three meetings, and 5% (n = 1)
never attended a meeting. Ninety five percent (n = 19) achieved normal LFTs and 5% (n = 1)
did not, see Appendix A.
Analysis
A multiple regression was run to predict percentage of TBW loss from adherence to a
Mediterranean diet, minutes walked each week, and group meeting attendance. The multiple
regression model statistically significantly predicted percentage of TBW loss, F (3, 16) = 6.355,
p = .005, R² = .54. Diet adherence was statistically significant to the prediction of percentage of
TBW loss, p = .006. However, minutes walked each week, p = .313, and group meeting
attendance, p = .210, were not statistically significant to the prediction of percentage of TBW
loss, see Appendix B.
A logistic regression analysis was performed to investigate the effects of diet adherence
and walking adherence on ultrasound outcome. Both predictor variables, diet adherence and
walking adherence, were tested a priori to verify that there was no violation of the assumption of
the linearity of the logit. The logistic regression model was not statistically significant. Neither
variable was found to contribute to the model. However, participants with greater diet adherence
were 1.75 times more likely to have a positive ultrasound outcome, with improved fibrosis, see
Appendix C.
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A Wilcoxon signed-rank test was conducted to determine what effect adhering to a
Mediterranean diet, walking 90 minutes each week, and attending six support group meetings
would have on hepatic ultrasound imaging, fibrosis score, weight, SBP, DBP, and triglycerides.
Pre-test and post-test variables were measured in each category. A histogram was used to assess
for normal distribution. As demonstrated in Table 1, there were no statistically significant results
and no median difference in the pre-intervention and post-intervention ultrasound imaging (Z =
-0.69, p = 0.49). However, fibrosis, weight, BMI, SBP, DBP, and triglycerides showed a
statistically significant median decrease in pre-intervention and post-intervention testing.
Table 1
Results of the Wilcoxon Signed-Rank Test Determining the Effect of a Mediterranean Diet,
Walking 90 Minutes Each Week, and Support Group Meetings on the Variables Listed
Pre-test

Post-test

Wilcoxon-Signed Rank Test

Variable

M

SD

M

SD

z

p

Ultrasound

.40

.50

.05

.22

-.69

.49

Fibrosis

2.15

.75

.65

.93

-3.91

.000

Weight

234.05

35.24

212.55

31.46

-3.92

.000

BMI

37.22

5.16

33.78

4.65

-3.92

.000

SBP

136.20

18.30

127.00

15.09

-3.40

.001

DBP

84.00

9.36

77.60

7.10

-2.93

.003

79.20

107.45

39.46

-3.92

.000

Triglycerides 169.60

Summary of Findings
A thorough analysis of this study’s findings revealed that 90% of participants achieved
5% TBW loss, with a statistically significant TBW loss, and reduced BMI. Diet adherence was
shown to be statistically significant to the prediction of percentage of TBW loss. However,
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minutes walked each week, and group meeting attendance were not statistically significant to the
prediction of percentage of TBW loss. With regard to ultrasound outcomes, diet adherence and
walking adherence were not found to be statistically significant; still, diet adherence was noted to
make a person 1.75 times more likely to have a positive ultrasound outcome, with improved
fibrosis. Improved post-intervention fibrosis scores, measured by Echosens FibroMeter, were
found to be statistically significant.
Dissemination of Findings
The data generated from this study will expound on the effect weight loss and exercise
has on NAFLD. This relatively small study, following 20 participants over a six-month period,
demonstrates the impact lifestyle behavior change has on slowing the disease progression of
NAFLD and serves to promote additional research on a larger patient population for an extended
period of time to demonstrate the long-term health outcomes of lifestyle intervention on NAFLD.
It is the intent of the investigator to disseminate the findings of this study to Southern
Adventist School of nursing faculty and students. Publication in peer reviewed nursing journals
is planned. This study can serve as a model for future studies to expand the knowledge and
understanding of the impact lifestyle medicine has on the treatment of NAFLD and advance
current clinical guidelines.
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Chapter 5
Discussion

NAFLD is the most common liver disease worldwide (Bellentani, 2017). It is regarded
as the liver component of metabolic syndrome. It is characterized by steatosis which is the
hepatic accumulation of triglycerides. Women are at greatest risk, typically peaking in the fifth
or sixth decade of life (Andronescu et al., 2018). NAFLD affects approximately 30% of the
United States population, with 5% progressing to the more aggressive form of the disease,
NASH. NASH can eventually progress into cirrhosis, which was the 11th leading cause of death
in 2017 in the United States (Kochanek et al., 2019). Cirrhosis resulting from NASH is
predicted to be the leading indication for liver transplantation in the United States (Corey &
Chalasani, 2014). Pharmacologic therapies have failed to provide long-term improvement
(Worcester, 2014).
While diet and exercise have been recognized as treatment strategies for diabetes and
cardiovascular disease, research is limited regarding such recommendations for treatment of
NAFLD. Though several studies evaluate the impact of diet on NAFLD and a fair amount of
these incorporate exercise and weight loss, few assess or even address the impact of social
connection and support, failing to recognize the importance of connecting mind, body, and spirit
in order to optimize long-term clinical outcomes.
The purpose of this study was to demonstrate improvement in NAFLD through lifestyle
intervention, leading to improved long-term health outcomes in patients with NAFLD, as well as
augmenting research on the treatment of NAFLD. This led to the clinical question: In patients
with NAFLD, does 1) adherence to a Mediterranean diet, 2) moderate exercise with walking 90
minutes per week, and 3) social support group meetings once monthly over a six-month period
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show disease improvement? Outcomes were measured by 1) 5% TBW loss, 2) improved hepatic
steatosis as measured by ultrasound, and 3) improved fibrosis staging.
This study consisted of 20 participants ranging from 18 to 78 years of age, with a mean of
53.55 years. Study participants were 85% female, 15% male, 85% Caucasian, 10% African
American, and 5% Hispanic. This is consistent with observations by Andronescu et al. (2018)
that NAFLD peaks between the ages of 50 to 60 years and that women are at greater risk for
developing NAFLD. Out of the 20 participants, 55% reported always following dietary
guidelines and 40% reported following at least half of the time; 60% walked 90 minutes each
week and 35% reported walking at least 45 minutes each week; 80% attended all six group
meetings, and 15% attended at least half of the meetings.
Ninety percent of participants achieved 5% TBW loss and 95% were noted to have
normal LFTs at the end of the six-months. Comparing pre- and post-intervention measurements,
there was a statistically significant improvement in fibrosis score, weight, BMI, BP, and
triglycerides. However, ultrasound results did not show any statistically significant
improvement. Diet adherence was the best prognosticator for percentage of TBW loss, while
walking and support group meeting attendance were not found to be significant predictors for
percentage of TBW loss. Likewise, neither diet adherence nor walking were statistically
significant predictors of positive ultrasound findings. However, this study did show that
participants who followed a Mediterranean diet were 1.75 times more likely to have positive
ultrasound outcomes.
Outcomes measured by 5% TBW loss and improved fibrosis staging measured through
Echosens FibroMeter were met, supporting the findings by Vilar-Gomez et al. (2015) who noted
TBW loss of 7% - 10% significantly improved NAFLD activity score. However, this study
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failed to meet improved hepatic steatosis as measured by ultrasound. Adhering to a
Mediterranean diet was the best indicator for outcomes, while walking and support group
meetings did not yield statistically significant findings. It is also important to acknowledge that,
while this study did not yield statistically significant findings in all three of the independent
variables for predicting outcomes, clinical significance warrants consideration. Out of 20
participants, 18 lost 5% of their TBW, 19 had normal LFTs at the end of six months, and serum
fibrosis staging measured by Echosens FibroMeter did show statistically significant
improvement. Factors that need to be considered are the small size of this study and participant
recall when answering the End of Study Participant Questionnaire. This was a small,
underpowered pilot study that lays the groundwork for a larger scale study to further explore the
impact of lifestyle medicine in the treatment of NAFLD.
Limitations and Future Research
Several limitations were identified in this study. Study participants were
disproportionately Caucasian females. Participant recall is more likely to be skewed over time,
making it difficult to accurately account for adherence to interventions. Length of the study may
not have been long enough to obtain post-intervention hepatic ultrasound imaging to yield
meaningful results. Finally, this study was too small to accurately measure the power of the
independent variables to predict the outcome of the dependent variables.
Future studies should include a larger population, 100 or more participants, to include
more diverse ethnic groups and gender distribution. Additionally, study participants need to be
followed over a longer period of time, one year or more, to better measure long-term outcomes
and further explore the impact lifestyle medicine has in the treatment of NAFLD. Future
research on this topic should employ a multi-disciplinary team approach that includes a medical
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provider who is well versed in lifestyle medicine, a dietician, an exercise therapist, and a lifestyle
coach. In doing so, diet and exercise can be more individualized, and study participants would
benefit from lifestyle coaching, both individually and in a group setting.
Implication for Advanced Practice Nursing
NAFLD and NASH affects approximately 30% of Americans. It is estimated that almost
100 million people living in the United States are living with NAFLD (“Liver Disease StatisticsAmerican Liver Foundation,” 2018). There are no current clinical guidelines that recommend
screening for NAFLD. Typically, patients are asymptomatic and NAFLD and NASH are
incidental findings when imaging is done for other reasons or when a patient’s liver chemistries
are elevated and imaging of the liver is ordered. As the number of patients diagnosed with
NAFLD continues to rise, NPs can expect to treat numerous patients with this disease. It is vital
for NPs to understand the prognosis of NAFLD and NASH, and how to optimize treatment for
their patients. This disease can be effectively treated, and for most, eliminated with lifestyle
modification. However, if changes are not made, patients with NAFLD and NASH are at a
much greater risk for development of cirrhosis.
This study validates the principles of lifestyle medicine for the treatment of NAFLD and
endorses future research on a larger scale over a longer period of time, so that the long-term
benefits and patient outcomes may be measured and better understood. NPs are in a unique
position to stand out as leaders in research, studying the impact lifestyle medicine has on chronic
disease, particularly NAFLD. The knowledge gained from this research will help shape and
advance current clinical guidelines.
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Demographics
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Appendix B
Multiple Regression
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Appendix C
Logistic Regression
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Appendix D

End of Study Participant Questionnaire

Name:___________________________________

Please circle the most appropriate response:
A. How often did you follow the Mediterranean diet:
0=Never
1=Less than half of the time
2=At least half of the time
3=Always
B. How many minutes did you walk each week (use your judgement to make an estimate):
0=Never
1=Less than 45 minutes each week
2=At least 45 minutes each week
3=90 minutes each week
C. How often did you attend monthly support group meetings (6 total):
0=Never
1=Less than 3 meetings
2=At least 3 meetings
3=Attended all 6 meetings

***This questionnaire is intended to help evaluate the effectiveness of the interventions used for
this study.
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Appendix E

End of Program Student Learning Outcomes and the Graduate Essentials
There are eight DNP essentials required for advanced nursing practice and completion of
a scholarly project. These include: I. Scientific Underpinnings for Practice; II. Organizational
and Systems Leadership for Quality Improvement and Systems Thinking; III. Clinical
Scholarship and Analytical Methods for Evidenced-Based Practice; IV. Information
Systems/Technology and Patient Care Technology for the Improvement and Transformation of
Health Care; V. Health Care Policy for Advocacy in Health Care; VI. Interprofessional
Collaboration for Improving Patient and Population Health Outcomes; VII. Clinical Prevention
and Population Health for Improving the Nation’s health; and VIII. Advanced Nursing Practice.
In addition to the eight DNP essentials, Southern Adventist University (SAU) has eight
student learning outcomes (SLO) that each scholarly project must satisfy for completion. These
SLOs are as follows: I. Cultural Competence; II. Evidence-Based Practice; III. Health
Promotion; IV. Patient-Centered Care; V. Quality and Safety; VI. Informatics and Innovation;
VII. Teamwork and Collaboration; and VIII. Professionalism.
The DNP essentials and SAU SLOs are very similar. Each requires the nurse practitioner
(NP) to conduct a scholarly project that exemplifies what they have learned in advanced nursing
practice, while utilizing nursing science integrated with knowledge from ethics, biophysical,
psychosocial, analytical, and organizational sciences. Both also require the NP to collaborate
with other members of the health care team to meet the needs of their patients while advancing
nursing practice and practice guidelines. Additionally, both require a professional and ethical
approach to care while being culturally sensitive to all those served by the NP.
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The Eight Essentials of Doctoral Education for Advanced Nursing Practice
The following outlines how this scholarly project fit the Essentials of Doctoral Education
for Advanced Nursing Practice.
I. Scientific Underpinnings for Practice. Through positive lifestyle changes, this study
promoted the well-being and optimal function of those with NAFLD. Through the actions of the
NP, participants learned about NAFLD and current treatment guidelines. Participants gained
improved health status as they improved their diet and physical activity. They also received
support from the NP, as well as others with NAFLD as they learned new lifestyle skills for
management of this disease. Additionally, this scholarly project provided further evidence for
the importance of Lifestyle Medicine in the management of chronic disease and promotes the
development of new practice approaches based on current guidelines as recommended by the
AGA and the AASLD.
II. Organizational and Systems Leadership for Quality Improvement and Systems
Thinking. This was exemplified through delivery of care to patients that promoted overall health
improvement. It incorporated principles of lifestyle medicine with nursing knowledge and
current practice guidelines.
III. Clinical Scholarship and Analytical Methods for Evidenced-Based Practice. An
extensive literature review was conducted using CINAHL and the AGA. There were 14 studies
reviewed, between the dates of 2004-2018. Analytical methods were utilized to critically
evaluate current literature to determine and implement the best evidence for practice. Utilization
of these guidelines integrated with lifestyle medicine was used to formulate and advance practice
guidelines.
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IV. Information Systems/Technology and Patient Care Technology for the Improvement
and Transformation of Health Care. Appropriate health care technology was utilized throughout
this project, examples include: utilization of the electronic medical record, conducting research
for this project, and diagnostics required for evaluating outcomes of lifestyle interventions.
V. Health Care Policy for Advocacy in Health Care. NAFLD has the propensity for
progression into cirrhosis. Current clinical guidelines do not recommend routine screening for
NAFLD in at risk populations. This study is intended to add to current research showing the
impact lifestyle medicine has on improving NAFLD and preventing cirrhosis. As we expand our
understanding of the treatment and management of NAFLD, research such as this can serve as a
catalyst for policy change.
VI. Interprofessional Collaboration for Improving Patient Population Health Outcomes.
This study seeks to implement lifestyle medicine into practice guidelines for the treatment of
NAFLD and calls for routine screening for at risk populations. This can be accomplished
through interprofessional collaboration utilizing peer review, collaborative efforts to design
practice guidelines, health policy, and standards of care.
VII. Clinical Prevention and Population Health for Improving the Nation’s Health.
NAFLD can be reversed, as long as it has not advanced to cirrhosis. This study utilized lifestyle
medicine to affect positive outcomes in patients with NAFLD. These principles can be used to
improve the health of the community, particularly those patients who are uninsured or
underinsured through community-based education opportunities.
VIII. Advanced Nursing Practice. This study promotes the advancement of nursing
practice by demonstrating care based on nursing science, integrated with sciences from other
disciplines. This study demonstrated advanced levels of clinical judgement, systems thinking,
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and accountability in design, delivering, and evaluating evidenced-based care to improve patient
outcomes. Additionally, information learned from this study can be used by other NPs to
improve nursing practice.
Southern Adventist Student Learning Outcomes
The following outlines how this study meets the eight SAU SLOs for advanced nursing
practice.
I. Cultural Competence. This scholarly project was open to participants from varying
ethnic backgrounds and did not discriminate based on color, ethnicity, gender, or socioeconomic
status. Additionally, this research was respectful of cultural customs when working within a
diverse patient population.
II. Evidence Based Practice. Current research and literature has been critically evaluated
to determine and implement the best evidence for practice. Utilization of current clinical
guidelines integrated with lifestyle medicine has been used to formulate the guidelines and
treatment interventions outlined in this study.
III. Health Promotion. NAFLD can be reversed for most patients, as long as it has not
advanced to cirrhosis. This study utilized lifestyle medicine to affect positive change in patients
with NAFLD leading to weight reduction and improved fibrosis staging.
IV. Patient Centered Care. Participants had improved health status through delivery of
patient centered care that promoted overall health and wellbeing. It incorporated Lifestyle
Medicine, utilizing principles from the Neuman Systems Model and CREATION Health Model
along with nursing knowledge and current practice guidelines.
V. Quality and Safety. Quality and safety concerns exist with regard to progression of
fibrosis, rather than improvement. Quality of care was maintained through utilizing current
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practice guidelines while seeking to expand on these through incorporating principles of lifestyle
medicine into the treatment of NAFLD. Risk to the patient was minimal, as invasive procedures
were limited to venipuncture.
VI. Informatics and Innovation. Examples of how informatics was used within this
study include, utilization of the electronic medical record (ensuring all patient information was
protected as required by HIPPA), and conducting internet-based research for this project.
Diagnostics, such as ultrasound and lab analysis, were used for evaluating outcomes of lifestyle
interventions. Additionally, SPSS was used for analysis of data collected from this scholarly
project.
VII. Teamwork and Collaboration. This scholarly project required an extensive
collaborative team, demonstrating teamwork in identifying potential study participants, advising,
lab/diagnostic collection and analysis, and dissemination of information. Additionally, SON
mentors and faculty provided valuable critique and guidance for this project.
VIII. Professionalism. Professionalism was demonstrated through honoring and
respecting the right to self-determination of each study participant, and promoting self-efficacy
while guiding them toward improved health.

